Gastroenterology
Volume 126, Issue 5 , Pages 1474-1477 , May 2004

Quality control for flexible sigmoidoscopy: which polyps count?

  • Ann G Zauber

      Affiliations

    • Corresponding Author InformationAddress requests for reprints to: Ann G. Zauber, Ph.D., Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 44, New York, New York 10021 USA; fax: (646) 735-0012
    • Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA

References 

  1. Winawer SJ, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, et al. Colorectal cancer screening and surveillance (clinical guidelines and rationale—update based on new evidence). Gastroenterology. 2003;124:544–560
  2. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman L, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365–1371
  3. Hardcastle JD, Chamberlain J, Robinson M, Moss S, Amar S, Balfour TW, et al. Randomised controlled trial of faecal-occult blood screening for colorectal cancer. Lancet. 1996;348:1472–1477
  4. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal occult blood test. Lancet. 1996;348:1467–1471
  5. Winawer SJ, Zauber AG, Ho MN, O’Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;329:1977–1981
  6. Citrada F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut. 2001;48:812–815
  7. Smith RA, von Eschenbach AC, Wender R, Levin B, Byers T, Rothenberger D, et al.  American Cancer Society guidelines for the early detection of cancer (update of early detection guidelines for prostate, colorectal, and endometrial cancers). CA Cancer J Clin. 2001;51:38–75 Also: update 2001-testing for early lung cancer detection.
  8. U.S. Preventive Services Task Force . Screening for colorectal cancer (recommendations and rationale). Ann Intern Med. 2002;137:129–131
  9. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk (a summary of the evidence for the U.S. Preventive Services Task Force). Ann Intern Med. 2002;137:132–141
  10. Atkin W, Rogers P, Cardwell C, Cook C, Cuzick J, Wardle J, et al. Wide variation in adenoma detection rates at screening flexible sigmoidoscopy. Gastroenterology. 2004;126:1247–1256
  11. UK Flexible Sigmoidoscopy Screening Trial Investigators . Single flexible sigmoidoscopy screening to prevent colorectal cancer (baseline findings of a UK multicentre randomized trial). Lancet. 2002;359:1291–1300
  12. Atkin W, Edwards R, Wardle J, Northover J, Sutton S, Hart A, et al. Design of a multicentre randomized trial to evaluate flexible sigmoidoscopy in colorectal cancer screening. J Med Screen. 2001;8:137–144
  13. Hofstad B, Almendingen K, Vatn M, Andersen SN, Owen RW, Larsen S, et al.  Growth and recurrence of colorectal polyps (a double-blind 3-year intervention with calcium and antioxidants). Digestion. 1998;59:148–156
  14. O’Brien MJ, Winawer SJ, Zauber AG, Gottlieb LS, Sternberg SS, Diaz B, et al. The National Polyp Study (patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas). Gastroenterology. 1990;98:371–379
  15. Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992;326:658–662
  16. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med. 2000;343:162–168
  17. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DR. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000;343:169–174
  18. Levin TR, Palitz A, Grossman S, Conell C, Finkler L, Ackerson L, et al. Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy. JAMA. 1999;281:1611–1617
  19. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer. Ann Intern Med. 2003;139:959–965
  20. Winawer SJ. Screening sigmoidoscopy (can the road to colonoscopy be less traveled?). Ann Intern Med. 2003;139:1034–1035
  21. Rex DK, Bond JH, Winawer S, Levin TR, Burt RW, Johnson DA, et al. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy (recommendations of the US multi-society task force on colorectal cancer). Am J Gastroenterol. 2002;97:1296–1308
  22. Hixson LJ, Fennerty MB, Sampliner RE, McGee D, Garewal H. Prospective study of the frequency and size distribution of polyps missed by colonoscopy. J Natl Cancer Inst. 1990;82:1769–1772
  23. Rex DK, Cutler CS, Lemmel GT, Rahmani EY, Clark DW, Helper DJ, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997;112:24–28
  24. Winawer SJ, Zauber AG, O’Brien MJ, Ho MN, Gottlieb L, Sternberg SS, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med. 1993;328:901–906
  25. Winawer SJ, Zauber AG. The advanced adenoma as the primary target of screening. Gastrointest Endosc Clin North Am. 2002;12:1–9
  26. Harvard Report on Cancer Prevention . Prevention of colon cancer in the United States. Cancer Causes Control. 1999;3:167–180
  27. Giovannucci E. An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2001;10:725–731
  28. Burt RW. Colon cancer screening. Gastroenterology. 2000;119:837–853
  29. Winawer SJ, Zauber AG, Gerdes H, O’Brien MJ, Gottlieb L, Sternberg SS, et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. N Engl J Med. 1996;334:82–87
  30. Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 2003;34:891–899
  31. Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med. 2003;348:883–890
  32. DuBois RN. Will an aspirin a day keep the endoscope away?. Gastroenterology. 2003;125:612–614
  33. Bertagnolli MM. The potential of non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention. J Surg Oncol. 2003;84:113–119
  34. Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Rothstein R, et al. Calcium supplements for the prevention of colorectal adenomas. N Engl J Med. 1999;340:101–107
  35. Morrison A. Screening in Chronic Disease. 2nd ed. New York, NY: Oxford; 1992;
  36. Brown ML, Klabunde CN, Mysliwiec P. Current capacity for endoscopic colorectal cancer screening in the United States (data from the National Cancer Institute survey of colorectal cancer screening practices). Am J Med. 2003;115:129–133
  37. Levin TR, Palitz AM. Flexible sigmoidoscopy (an important screening option for average-risk individuals). Gastrointest Endosc Clin North Am. 2002;12:23–40

PII: S0016-5085(04)00482-2

doi: 10.1053/j.gastro.2004.03.029

Gastroenterology
Volume 126, Issue 5 , Pages 1474-1477 , May 2004

Article Tools